Aslan needed to focus intensely on clinical trials in Australia without the hassle of maintaining corporate compliance. Acclime’s services to take care of all compliance issues in the administration of the subsidiary was essential.
ASLAN Pharmaceuticals is a clinical-stage immunology and oncology focused biopharmaceutical company developing innovative treatments to transform the lives of patients.
Acclime have been a key partner in the establishment of our business in Australia. They have provided crucial advice to ensure that all aspects of our business are fully compliant with Australian regulations, allowing us to focus more effectively on advancing our clinical trial program.
Kiran Asarpota
VP Finance, Aslan Pharmaceuticals
Blair Lucas, Acclime Partner
Liability limited by a scheme approved under Professional Standards Legislation.